[
    [
        {
            "time": "",
            "original_text": "项新冠肺炎临床试验深入盘点：拟入组超15000名患者，四成涉及中医药，单抗最受关注！",
            "features": {
                "keywords": [
                    "新冠肺炎",
                    "临床试验",
                    "中医药",
                    "单抗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "项新冠肺炎临床试验深入盘点：拟入组超15000名患者，四成涉及中医药，单抗最受关注！",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药行情恢复理性 机构建议关注长期向好的核心资产",
            "features": {
                "keywords": [
                    "医药行情",
                    "恢复理性",
                    "核心资产"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行情恢复理性 机构建议关注长期向好的核心资产",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "19药企参与新冠病毒疫苗研发，部分产品进入动物实验阶段",
            "features": {
                "keywords": [
                    "药企",
                    "新冠病毒",
                    "疫苗研发",
                    "动物实验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "19药企参与新冠病毒疫苗研发，部分产品进入动物实验阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]